5777 W. Century Blvd. Suite 360

Los Angeles, CA 90045

310-258-5000

INDUSTRY EXPERT ENDORSES COMPUMED'S OPO SOLUTION

LOS ANGELES, CA (September 4, 2014) - CompuMed's (OTCPink: CMPD) Enterprise Organ Procurement Organization (OPO) Solution has been recommended by Karen Rago as the premier solution in the marketplace to enable OPOs to place more hearts and maximize organ yield. Enterprise OPO delivers real-time diagnostic exam interpretations and Critical Care Consulting by Board-Certified specialists, in areas such as serial echocardiogram, electrocardiogram (ECG), chest x-ray, and computerized tomography (CT). CompuMed's on-call specialist coverage for organ donor cases can save OPOs 10 or more hours per case and is available 24/7.

"Few hospitals have 24/7 echocardiogram capabilities, which is what makes CompuMed OPO so critical in preserving the viability of donor organs. In addition, the Critical Care Consulting that is delivered by CompuMed's Board-Certified cardiologists and pulmonologists helps OPOs to recover more organs. For OPOs that wish to bring technical exam administration in-house, CompuMed offers training programs for OPO coordinators so they can become skilled in administering echos in order to further reduce costs and control quality," said Karen Rago, former Executive Director, at The University of California San Francisco (UCSF) Medical Center.

Karen Rago has over 30 years of hospital administration experience, including a distinguished career as Executive Director of The UCSF Medical Center. The University of California San Francisco Medical Center specializes in heart and lung transplants.

"Ms. Rago's endorsement of CompuMed Enterprise OPO speaks to the unique value proposition that this solution provides OPOs. Our organ procurement organization customers are further validating her words by increasing their numbers of recoverable organs through the use of our services. We're truly humbled by the opportunity to support OPOs in saving more lives," said W. Scott Rombach, CompuMed's President and CEO.

Details of CompuMed's Enterprise OPO Solution can be viewed at compumedinc.com.

About CompuMed, Inc.

CompuMed, Inc. (OTCPink: CMPD) Enterprise Telemedicine Solutions provide patients with the highest level of clinical care at reduced costs. Its telecardiology and teleradiology offerings provide real-time access to U.S. Board-Certified specialists through cloud-based technology and integrated medical devices to medical facilities anywhere in the world. The company has been in business over 26 years and services over 1,000 clinical settings. CompuMed is headquartered in Los Angeles, CA. Visit CompuMed at www.compumedinc.com.

Forward-Looking Statements

Statements contained in this report, such as statements about revenue, operations, and earnings growth and other financial results are
forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including statements concerning the Company's plans, objectives, expectations and intentions are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These statements are subject to uncertainties and risks including, without limitation, product and service demand and acceptance, changes in technology, ability to raise capital, the availability of appropriate acquisition candidates and/or business partnerships, economic conditions, the impact of competition and pricing, capacity and supply constraints or difficulties, government regulation and other risks identified in the Company's filings with the Securities and Exchange Commission and OTC Pink operated by OTCMarkets. All such forward -looking statements are expressly qualified by these cautionary statements. The Company expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements to reflect events, conditions or circumstances on which any such statement is based after the date hereof, except as required by law.

CompuMed, Inc. Investor Relations: investorrelations@compumed.net or (310) 258-5000 x117

distributed by